Depend® and Sports Icons Unite for Prostate Cancer Awareness Campaign

Depend® Collaborates with Ken Griffey Jr. and Sr. for Men's Health Awareness

In a bold initiative aimed at fostering conversations around prostate cancer, Depend®, a leading brand in personal care products, has joined hands with sports greats Ken Griffey Jr. and Sr., alongside Emmitt Smith. This partnership marks the sixth year of the Stand Strong for Men's Health campaign, which is rolled out in time for Prostate Cancer Awareness Month. Given that one in eight men is diagnosed with prostate cancer, the campaign seeks to break the silence surrounding this prevalent yet often stigmatized condition.

Prostate cancer is not only a health concern but can also lead to complications like bladder leaks, an issue that many men feel uncomfortable discussing. Riding on the insights from personal experiences, Griffey Jr. and Sr. aim to spread the message that awareness, early detection, and open dialogue are key to tackling this disease head-on.

In the campaign, Ken Griffey Jr. shares, "Prostate cancer has impacted my family deeply, leading me to advocate for early screenings. A simple blood test can significantly improve treatment options and success rates. I encourage all men to communicate with their healthcare providers about their health."

Emmitt Smith adds to the conversation, highlighting the importance of community discussions in normalizing the talk around prostate health. He states, "Having seen my father navigate this battle, I appreciate the significance of sharing our experiences. Prostate cancer is just as prevalent as breast cancer, and the statistics are alarming for men of color, who face a 70% higher likelihood of diagnosis. We can change the narrative by encouraging open dialogues in our homes and communities, aiming to catch this disease earlier and save lives."

Since the inception of its Stand Strong for Men's Health™ campaign back in 2020, Depend® has contributed over $1 million to the Prostate Cancer Foundation. This funding plays a critical role in the advancement of prostate cancer research, ultimately aiding in the development of improved treatment options.

With Prostate Cancer Awareness Month coinciding with Men’s Health Awareness Month, Depend® pledges to donate up to $300,000 from specific product sales to the Prostate Cancer Foundation’s mission. Purchases of Depend® Guards, Depend® Shields, and Depend® Real-Fit products will help in this vital fundraising endeavor between September 1, 2024, and November 30, 2024.

Griffey Jr. reflects on his father's fight against prostate cancer, emphasizing the need for societal discussions on bladder leakage, which often accompanies the disease. He reassures men that they are not alone in this journey and that Depend® products can help restore their confidence and quality of life.

Advancements in prostate cancer diagnostics, funded by the Prostate Cancer Foundation, include the development of the prostate-specific membrane antigen (PSMA)-PET scan. This cutting-edge technology significantly enhances the ability to detect prostate cancer, often catching it earlier and more effectively than traditional imaging approaches.

For more insights about the Stand Strong for Men's Health™ campaign, interested individuals can visit Depend.com/Stand-Strong. To learn about the Prostate Cancer Foundation and the contributions made by Depend®, please check out pcf.org/depend.

The Prostate Cancer Foundation, founded in 1993 by Mike Milken, is recognized as a leading philanthropic organization dedicated to funding pioneering prostate cancer research worldwide. With nearly a billion dollars raised to date, the foundation has significantly impacted the survival rates and quality of life for men diagnosed with this disease.

As Depend® continues to utilize its platform for advocacy, it invites everyone to join the conversation, encouraging men to seek support and information concerning their health and prostate cancer detection. Let's break the barriers of silence and empower each other toward better health outcomes.